GSK3179106 is an orally active, selective RET kinase inhibitor for human and rat RET IC50 0.4 nM and 0.2 nM, respectively. GSK3179106 has the potential for use in irritable bowel syndrome (IBS) by reducing post-inflammatory and stress-induced visceral hy
Molekulargewicht:
467.41
Reinheit:
>99%
CAS Nummer:
[1627856-64-7]
Formel:
C22H21F4N3O4
Target-Kategorie:
RET
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
